Diabetes Care Devices Market Expected to Reach $10,208 Million | Find Out Top Impacting Factor of Market Growth By Opportunity and Industry Forecast, 2017-2023

Global Diabetes Care Devices Market was valued at $6,867 million in 2016, and is estimated to reach $10,208 million by 2023, growing at a CAGR of 5.8% from 2017 to 2023. Diabetes care devices are used to monitor the level of glucose into a diabetic patient’s body. These devices also facilitate in delivery of insulin into the patient’s body.

Request For PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2842

Diabetes care devices are used to test the blood glucose level in a patients body. These devices are also used to deliver insulin to the body of a diabetic patient.

The major factor that contributes to the growth of the market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boost the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth. Rise in awareness about diabetes monitoring devices and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.

The blood glucose monitoring devices segment is expected to maintain its dominant position during the analysis period, owing to rise in the prevalence of diabetes, increase in geriatric population, high demand of self-care, and technological advancements in blood glucose monitoring devices. In addition, blood glucose is the first step in the treatment of a diabetic patient to check the level of glucose in blood. Hence, blood glucose monitoring devices are used by almost every person who is diagnosed with diabetes. This is not the case with insulin delivery devices, as every patient diagnosed with diabetes need not take insulin injections.

Key Findings of the Diabetes Care Devices Market:

• Blood glucose monitoring devices segment accounted for more than half of the global market share in 2016
• Insulin delivery devices segment is expected to grow at a CAGR of 6.0% from 2017 to 2023
• Testing strips accounted for nearly two-fifths of the global market in 2016
• Insulin pumps accounted for more than one-third of the global market in 2016
• Asia-Pacific is expected to grow at the highest CAGR of 6.9%, from 2017 to 2023

North America accounted for more than two-fifths share of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes, growth in geriatric population, and adoption of sedentary lifestyle of people that leads to diabetes. In addition, high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructure are expected to present new growth opportunities to the players in this market.

The major companies profiled in the report include

• Abbott Laboratories,
• ACON Laboratories, Inc.,
• Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG),
• Becton,
• Dickinson and Company,
• Dexcom, Inc.,
• F. Hoffmann-La Roche Ltd,
• Johnson & Johnson,
• Medtronic plc,
• Novo Nordisk A/S, and
• Terumo Corporation.

For Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/2842

Table Of Content


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.4.4. Impact analysis

3.5. CLINICAL TRIALS

Access Full Summery @ https://www.alliedmarketresearch.com/diabetes-care-devices-market

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.